ULISSE BIOMED SPA (UBM.MI) Stock Income Statement
Europe - BIT:UBM - IT0005451213 - Common Stock
0.806 EUR
+0.02 (+2.28%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 925.90K | 767.90K | 66.20K | 138.40K | 276.60K | |||
| Cost Of Goods | 1.73M | 1.84M | 1.62M | 1.03M | 545.90K | |||
| Gross Profit | -804.50K | -1.08M | -1.55M | -894.80K | -269.20K | |||
| Operating Expenses | 4.48M | 4.83M | 3.25M | 411.60K | 334.20K | |||
| Selling, General, and Administrative Expenses | 1.40M | 1.77M | 497.30K | 330.00K | 140.80K | |||
| Operating Income | -5.28M | -5.91M | -4.80M | -1.31M | -603.40K | |||
| Interest Income/Expense | -16.90K | -28.70K | -300.00 | -1.40K | -400.00 | |||
| Other Income/Expense | N/A | 0.00 | N/A | 100.00 | 200.00 | |||
| Income Before Taxes | -5.30M | -5.94M | -4.80M | -1.31M | -603.60K | |||
| Income Tax | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| Net Income | -5.30M | -5.94M | -4.80M | -1.31M | -603.60K | |||
| EBITDA | -2.25M | -2.99M | -2.29M | -986.80K | -355.70K | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.21 | -0.24 | -0.58 | -0.16 | -0.07 | |||
| Statistics | ||||||||
| Gross Profit Margin | -86.89% | -140.16% | -2340.03% | -646.53% | -97.32% | |||
| Profit Margin | -572.61% | -773.51% | -7246.07% | -944.94% | -218.22% | |||
| Operating Profit Margin | -570.79% | -769.77% | -7245.47% | -943.93% | -218.15% | |||
All data in EUR